Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
Status: Enrolling
Updated:  12/31/1969
West Coast Retina Medical Group
mi
from
San Francisco, CA
Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
Status: Enrolling
Updated: 12/31/1969
West Coast Retina Medical Group
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation and Treatment of People With Eye Diseases
Evaluation and Treatment Protocol for Potential Research Participants With Ocular Diseases
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation and Treatment of People With Eye Diseases
Evaluation and Treatment Protocol for Potential Research Participants With Ocular Diseases
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
WAGR Syndrome and Other 11p Contiguous Gene Deletions: Clinical Characterization and Correlation With Genotype
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
WAGR Syndrome and Other 11p Contiguous Gene Deletions: Clinical Characterization and Correlation With Genotype
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Endothelial Keratoplasty Outcomes
Open-enrollment, Prospective Study of Endothelial Keratoplasty Outcomes
Status: Enrolling
Updated:  12/31/1969
Price Vision Group
mi
from
Indianapolis, IN
Study of Endothelial Keratoplasty Outcomes
Open-enrollment, Prospective Study of Endothelial Keratoplasty Outcomes
Status: Enrolling
Updated: 12/31/1969
Price Vision Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Clinical Evaluation of Morcher Artificial Iris Diaphragms
Clinical Evaluation of Morcher Artificial Iris Diaphragms to Treat Light and Glare Sensitivity in Partial or Complete Aniridia
Status: Enrolling
Updated:  12/31/1969
Stein Eye Institute (UCLA)
mi
from
Los Angeles, CA
Clinical Evaluation of Morcher Artificial Iris Diaphragms
Clinical Evaluation of Morcher Artificial Iris Diaphragms to Treat Light and Glare Sensitivity in Partial or Complete Aniridia
Status: Enrolling
Updated: 12/31/1969
Stein Eye Institute (UCLA)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
Does a New Add on (or Adjunctive) Therapy Used in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute, Glaucoma Service
mi
from
Philadelphia, PA
Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
Does a New Add on (or Adjunctive) Therapy Used in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute, Glaucoma Service
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
The Effect of Intracameral Triesence (Triamcinolone Acetonide Injectable Suspension) on Ocular Inflammation After Trabeculectomy, Tube Shunt Implantation or Combined Trabeculectomy With Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute
mi
from
Philadelphia, PA
Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
The Effect of Intracameral Triesence (Triamcinolone Acetonide Injectable Suspension) on Ocular Inflammation After Trabeculectomy, Tube Shunt Implantation or Combined Trabeculectomy With Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Retinal and Ophthalmic Consultants
mi
from
Houston, TX
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Retinal and Ophthalmic Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Greider Eye Associates
mi
from
Vista, CA
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Greider Eye Associates
mi
from
Vista, CA
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Palm Beach Eye Center
mi
from
Atlantis, FL
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Palm Beach Eye Center
mi
from
Atlantis, FL
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
West Coast Eye Care
mi
from
Fort Myers, FL
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
West Coast Eye Care
mi
from
Fort Myers, FL
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Midwest Eye Institute
mi
from
Indianapolis, IN
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Midwest Eye Institute
mi
from
Indianapolis, IN
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Spoor and Associates
mi
from
Warren, MI
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Spoor and Associates
mi
from
Warren, MI
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Asheville Eye Associates
mi
from
Asheville, NC
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Asheville Eye Associates
mi
from
Asheville, NC
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Office of Dr. Avrom Epstein, MD
mi
from
Columbus, OH
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Office of Dr. Avrom Epstein, MD
mi
from
Columbus, OH
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Tulsa Clinical Research
mi
from
Tulsa, OK
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Tulsa Clinical Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Save Sight Institute
mi
from
Sydney,
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Save Sight Institute
mi
from
Sydney,
Click here to add this to my saved trials
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
Treatment of Non-infectious Panuveitis, Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
Treatment of Non-infectious Panuveitis, Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
Genotypic Evaluation of Chronic Exudative Macular Degeneration Despite Monthly Anti-Vascular Endothelial Growth Factor (VEGF) Therapy
Status: Enrolling
Updated:  12/31/1969
West Coast Retina Medical Group
mi
from
San Francisco, CA
Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
Genotypic Evaluation of Chronic Exudative Macular Degeneration Despite Monthly Anti-Vascular Endothelial Growth Factor (VEGF) Therapy
Status: Enrolling
Updated: 12/31/1969
West Coast Retina Medical Group
mi
from
San Francisco, CA
Click here to add this to my saved trials
Does Glaucoma Cause Loss of Brain Function?
Neuroimaging Brain Changes in Glaucoma
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute, Glaucoma Service
mi
from
Philadelphia, PA
Does Glaucoma Cause Loss of Brain Function?
Neuroimaging Brain Changes in Glaucoma
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute, Glaucoma Service
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Spaeth/Richman Contrast Sensitivity Test
Validation and Reproducibility of Spaeth/Richman Contrast Sensitivity Test
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute
mi
from
Philadelphia, PA
Spaeth/Richman Contrast Sensitivity Test
Validation and Reproducibility of Spaeth/Richman Contrast Sensitivity Test
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Abatacept in the Treatment of Uveitis
An Openlabel, Phase II Trial of Abatacept (Orencia) in the Treatment of Refractory Non-infectious Uveitis.
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Abatacept in the Treatment of Uveitis
An Openlabel, Phase II Trial of Abatacept (Orencia) in the Treatment of Refractory Non-infectious Uveitis.
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Sirolimus as Therapeutic Approach to Uveitis
A Phase 1, Open-label, Randomized Clinical Study to Assess the Safety, Tolerability and Bioactivity of Intravitreal and Subconjunctival Injection of Sirolimus in Patients With Non-infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Wilmer Eye Institute, Johns Hopkins University
mi
from
Baltimore, MD
Sirolimus as Therapeutic Approach to Uveitis
A Phase 1, Open-label, Randomized Clinical Study to Assess the Safety, Tolerability and Bioactivity of Intravitreal and Subconjunctival Injection of Sirolimus in Patients With Non-infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Wilmer Eye Institute, Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
Status: Enrolling
Updated:  12/31/1969
Southern California College of Optometry
mi
from
Fullerton, CA
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
Status: Enrolling
Updated: 12/31/1969
Southern California College of Optometry
mi
from
Fullerton, CA
Click here to add this to my saved trials
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
Status: Enrolling
Updated:  12/31/1969
Duke University Eye Center
mi
from
Durham, NC
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
Status: Enrolling
Updated: 12/31/1969
Duke University Eye Center
mi
from
Durham, NC
Click here to add this to my saved trials
Steroids After Laser Trabeculoplasty for Glaucoma
Steroids And Laser Trabeculoplasty (SALT) Trial: Effect of Anti-Inflammatory Treatment on the Efficacy of SLT
Status: Enrolling
Updated:  12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Steroids After Laser Trabeculoplasty for Glaucoma
Steroids And Laser Trabeculoplasty (SALT) Trial: Effect of Anti-Inflammatory Treatment on the Efficacy of SLT
Status: Enrolling
Updated: 12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Steroids After Laser Trabeculoplasty for Glaucoma
Steroids And Laser Trabeculoplasty (SALT) Trial: Effect of Anti-Inflammatory Treatment on the Efficacy of SLT
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Steroids After Laser Trabeculoplasty for Glaucoma
Steroids And Laser Trabeculoplasty (SALT) Trial: Effect of Anti-Inflammatory Treatment on the Efficacy of SLT
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Mycotic Ulcer Treatment Trial I
Mycotic Ulcer Treatment Trial
Status: Enrolling
Updated:  12/31/1969
Proctor Foundation, UCSF
mi
from
San Francisco, CA
Mycotic Ulcer Treatment Trial I
Mycotic Ulcer Treatment Trial
Status: Enrolling
Updated: 12/31/1969
Proctor Foundation, UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Mycotic Ulcer Treatment Trial I
Mycotic Ulcer Treatment Trial
Status: Enrolling
Updated:  12/31/1969
Aravind Eye Hospitals
mi
from
Madurai,
Mycotic Ulcer Treatment Trial I
Mycotic Ulcer Treatment Trial
Status: Enrolling
Updated: 12/31/1969
Aravind Eye Hospitals
mi
from
Madurai,
Click here to add this to my saved trials
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated:  12/31/1969
Proctor Foundation, UCSF
mi
from
San Francisco, CA
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated: 12/31/1969
Proctor Foundation, UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated:  12/31/1969
Aravind Eye Hospital
mi
from
Coimbatore,
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated: 12/31/1969
Aravind Eye Hospital
mi
from
Coimbatore,
Click here to add this to my saved trials
Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis
A Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 to the Retinal Pigment Epithelium (RPE) [AAV2-hRPE65v2-301]
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis
A Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 to the Retinal Pigment Epithelium (RPE) [AAV2-hRPE65v2-301]
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis
A Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 to the Retinal Pigment Epithelium (RPE) [AAV2-hRPE65v2-301]
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis
A Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 to the Retinal Pigment Epithelium (RPE) [AAV2-hRPE65v2-301]
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®) Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects With Choroidal Neovascularization (CNV) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  12/31/1969
Valley Retina Institute
mi
from
Harlingen, TX
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®) Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects With Choroidal Neovascularization (CNV) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Valley Retina Institute
mi
from
Harlingen, TX
Click here to add this to my saved trials
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®) Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects With Choroidal Neovascularization (CNV) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins - The Wilmer Eye Institute
mi
from
Baltimore, MD
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®) Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects With Choroidal Neovascularization (CNV) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins - The Wilmer Eye Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®) Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects With Choroidal Neovascularization (CNV) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  12/31/1969
Palmetto Retina Center
mi
from
West Columbia, SC
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®) Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects With Choroidal Neovascularization (CNV) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Palmetto Retina Center
mi
from
West Columbia, SC
Click here to add this to my saved trials
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®) Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects With Choroidal Neovascularization (CNV) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  12/31/1969
Hotel Dieu de Paris Hospital
mi
from
Paris,
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®) Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects With Choroidal Neovascularization (CNV) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Hotel Dieu de Paris Hospital
mi
from
Paris,
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Center for Excellence in Eye Care
mi
from
Miami, FL
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Center for Excellence in Eye Care
mi
from
Miami, FL
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
TLC Laser Eye Center
mi
from
Rockville, MD
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
TLC Laser Eye Center
mi
from
Rockville, MD
Click here to add this to my saved trials
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
TLC Laser Eye Center
mi
from
Fairfax, VA
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
TLC Laser Eye Center
mi
from
Fairfax, VA
Click here to add this to my saved trials
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
investigational site number 03WilmerEy
mi
from
Baltimore, MD
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
investigational site number 03WilmerEy
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
investigational site number 02Ophthalm
mi
from
Boston, MA
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
investigational site number 02Ophthalm
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
investigational site number 01UMassMem
mi
from
Worcester, MA
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
investigational site number 01UMassMem
mi
from
Worcester, MA
Click here to add this to my saved trials
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
investigational site number 05RetinaCo
mi
from
Slingerlands, NY
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
investigational site number 05RetinaCo
mi
from
Slingerlands, NY
Click here to add this to my saved trials
Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System
Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System
Status: Enrolling
Updated:  12/31/1969
Laser Vision Medical Associates
mi
from
Los Angeles, CA
Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System
Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System
Status: Enrolling
Updated: 12/31/1969
Laser Vision Medical Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials